What are the prospects for early diagnosis, CRISPR gene-editing, and CAR T-cell therapies in myeloma?

What does the new cancer research mean for patients? IMF Chairman Dr. Brian G.M. Durie sees a fresh take on MGUS, the curative potential of cloning, and questions on the value of early diagnosis.

Top Five Trends in Myeloma News for 2018

As the new year begins, important developments that will impact patients have been in the news, ranging from molecular testing to new therapies for myeloma. The depth and scope of these reports reflect what I think are five key trends for 2018 and beyond.

Rapidly Expanding CRISPR Toolbox Could Make Us All Healthier and Save the Planet

Rapidly expanding CRISPR toolbox could make us all healthier and save the planet

Two recent publications in the prestigious journals Nature and Science illustrate how gene editing can be further enhanced. In The Scientist, Catherine Offord provides an excellent summary of both the scientific details and the implications. The implications are so far-reaching that not only can prevention of disease become possible, but the food chain can be made healthier without the use of dangerous toxic chemicals and the impact of global pollution can be reduced. 

How Gene Editing Can Help Lead to a Cure (Part Two) and the 2017 Nobel Prizes for Science

In last week’s blog post, I discussed the ways in which CRISPR gene-editing technology is allowing researchers to study disease and intervene at the molecular level. There is a sense of euphoria that so many things can be accomplished and, as I noted, the sky is the limit in the potential applications.

Can New Gene-Editing Tools Provide the Roadmap to A Cure for Myeloma?

CRISPR technology was the 2015 science breakthrough of the year. The discovery and implementation of this technology has set off a revolution in genetic research and treatment. But what does it mean for cancer, and specifically, might CRISPR technology be used to help find a cure for myeloma?

Pages